SCHEMBL2182909

SCHEMBL2182909

CN(/N=C/c1ccccc1F)c1cc(=O)n(C)c(=O)[nH]1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.62
KDM4E B2RXH2 5/20 0.58
ALDH1A1 P00352 4/20 0.58
THRB P10828 2/20 0.58
HPGD P15428 2/20 0.58
KDM4C Q9H3R0 2/20 0.56
PKM P14618 2/20 0.50
GAA P10253 2/20 0.50
LMNA P02545 2/20 0.50
NR1I2 O75469 1/20 0.43
AHR P35869 1/20 0.43
KMT2A Q03164 2/20 0.41
BRCA1 P38398 2/20 0.41
MEN1 O00255 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NPC1 O15118 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2182912 1.00 SMN1; SMN2 (0.62) SMN1; SMN2KDM4EALDH1A1THRBHPGD
SCHEMBL2179941 0.80 KDM4E (0.67) SMN1; SMN2KDM4EALDH1A1THRBHPGD
SCHEMBL2179940 0.80 KDM4E (0.67) SMN1; SMN2KDM4EALDH1A1THRBHPGD
SCHEMBL2183949 0.77 SMN1; SMN2 (0.61) SMN1; SMN2KDM4EALDH1A1THRBHPGD
SCHEMBL2183954 0.77 SMN1; SMN2 (0.61) SMN1; SMN2KDM4EALDH1A1THRBHPGD
SCHEMBL3474334 0.77 SMN1; SMN2 (1.00) SMN1; SMN2KDM4EALDH1A1THRBHPGD
SCHEMBL2182128 0.76 SMN1; SMN2 (0.61) SMN1; SMN2KDM4EALDH1A1THRBHPGD
SCHEMBL2182131 0.76 SMN1; SMN2 (0.61) SMN1; SMN2KDM4EALDH1A1THRBHPGD
SCHEMBL2180529 0.76 KDM4E (0.65) SMN1; SMN2KDM4EALDH1A1THRBHPGD
SCHEMBL2180526 0.76 KDM4E (0.65) SMN1; SMN2KDM4EALDH1A1THRBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same DPYD, TYMP, DHFR SMN1; SMN2 2741/4885KDM4E 4180/4885ALDH1A1 245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.